4-TERT-BUTYL 2-METHYL 2-METHYLMORPHOLINE-2,4-DICARBOXYLATE, 95.0%, 100mg

TERT-BUTYL 3-(NITROMETHYLENE)AZETIDINE-1-CARBOXYLATE, 95.0%, 10g

6-Isopropoxypyridin-3-ol, 97%, 100mg

N-[2-[[4-[4-(3-Bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]sulfamide, 95%, 250mg

2-Feniletanol, min 99%, para síntesis, 5 ml, envase de vidrio

(2,2-Difluoro-benzo[1,3]dioxol-4-yl)-methanol, 95.0%, 5g

(E)-N-[4-amino-1-(pyridin-3-yl)butylidene]hydroxylamine hydrochloride, 95.0%, 2g

2-Amino-5-bromo-3-piperidin-1-ylpyrazine, 95.0%, 5g

6,7-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 1g

(2-Chloro-6-methylpyridin-4-yl)boronic acid, 95.0%, 1g

Di-tert-butyl 1-(4-fluoro-3,5-dimethylphenyl)hydrazine-1,2-dicarboxylate, 98%, 10g

3-Hydroxy-4-(methoxycarbonyl)benzoic acid, 97%, 5g

2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid, 95%, 5g